Medicenna Therapeutics Corp. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Medicenna Therapeutics Corp. (MDNAF) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of CAD 1.65 million for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2023-06-27
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2023-03-31 | 1.65M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | -173.00K CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | -208.00K CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | -39.00K CAD 20-F · filed 2022-06-22 |